Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant.
Saved in:
| Title: | Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant. |
|---|---|
| Authors: | Lewis JH; Department of Gastroenterology and Hepatology, Georgetown University Medical Center, Washington, DC, USA. lewisjh9205@gmail.com., Andrade RJ; Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd, Málaga, Spain., Larrey D; Liver Unit, Saint-Eloi Hospital, Montpellier School of Medicine, Montpellier, France., Horsmans Y; Department of Hepato-Gastroenterology, Cliniques Universitaires Saint-Luc et Institut de Recherche Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium., Anderson RA; Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK., Trajanovic M; Bayer US LLC, Whippany, NJ, USA., Groettrup-Wolfers E; Bayer AG, Berlin, Germany., Zuurman L; Bayer CC, Basel, Switzerland. |
| Source: | Drug safety [Drug Saf] 2026 Aug; Vol. 49 (8), pp. 985-1002. Date of Electronic Publication: 2026 Mar 18. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
